To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene KDELR2andDAGLBTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
744 representative clones for gene KDELR2andDAGLB back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_139179.3   .a 1 to 2910 1 to 2910 exact RefSeq,   2910/2910
(100 %)
0 diff
(100 %id)
DC346979 tongue, tumor tissue .a 32 to 595 1 to 564   tiling clone,   564/564
(100 %)
1 diff
(99.9 %id)
BI754332 brain .a 40 to 857 1 to 825       825/938
(87 %)
25 diff
(97.4 %id)
CA488691   .a 40 to 932 1 to 897       897/897
(100 %)
10 diff
(98.9 %id)
TI_57215781   .a 40 to 857 33 to 857       825/970
(85 %)
30 diff
(97.0 %id)
DA297324 hippocampus .a 41 to 620 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DC309305 cerebellum .a 53 to 606 1 to 554       554/554
(100 %)
0 diff
(100 %id)
DA941319 Spleen .a 55 to 650 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
DA371651 thalamus .a 57 to 623 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB137528 thymus .a 57 to 631 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
AF450090 placenta .a 59 to 2896 1 to 2839   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2839/2839
(100 %)
2 diff
(100.0 %id)
BP362279 thalamus .a 59 to 640 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA158965 amygdala .a 60 to 624 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA437036 tongue, tumor tissue .a 60 to 635 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA452890 tongue, tumor tissue .a 60 to 625 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA471236   .a 60 to 608 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA523970 brain .a 60 to 635 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
TI_57182430   .a 60 to 970 27 to 939       911/940
(96 %)
23 diff
(97.6 %id)
DA746582   .a 60 to 617 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA772299 brain .a 60 to 623 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA838087 placenta .a 60 to 606 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DB020540 testis .a 60 to 607 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB159752 thymus .a 60 to 652 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DA016105 adrenal gland .a 61 to 619 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
AK074744   .a 61 to 2896 1 to 2836   available from FLJ,   2836/2836
(100 %)
3 diff
(99.9 %id)
BP251741 hippocampus .a 61 to 643 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DB055412 testis .a 61 to 628 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
AK075128 placenta .a 62 to 2896 1 to 2835   tiling clone, available from FLJ,   2835/2835
(100 %)
0 diff
(100 %id)
DA073951 cerebellum .a 62 to 634 2 to 573   capped   574/572
(100 %)
3 diff
(99.5 %id)
DA111014 cerebellum .a 62 to 638 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA273461 caudate nucleus .a 62 to 611 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA352771 substantia nigra .a 62 to 646 2 to 587   capped   586/586
(100 %)
2 diff
(99.7 %id)
DA437772 tongue, tumor tissue .a 62 to 650 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
DA438746 tongue, tumor tissue .a 62 to 631 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA487119 brain .a 62 to 632 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA553131   .a 62 to 636 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA657831   .a 62 to 631 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA730813   .a 62 to 846 2 to 789   capped   788/861
(91 %)
13 diff
(98.5 %id)
DA777757 brain .a 62 to 633 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA780608 brain .a 62 to 640 2 to 582   capped   581/583
(99 %)
4 diff
(99.4 %id)
DA939340 Spleen .a 62 to 648 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DB033800 testis .a 62 to 605 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA619727   .a 63 to 648 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
BP307087   .a 65 to 646 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BI771913 pooled lung and spleen .a 66 to 970 1 to 907       905/908
(99 %)
18 diff
(98.1 %id)
DA024633   .a 68 to 648 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA050627   .a 68 to 642 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BX463519 adult brain, brain .a 71 to 1083 1 to 1005       1005/1009
(99 %)
21 diff
(98.0 %id)
CB989784 Human Placenta, placenta .a 71 to 820 21 to 773       753/792
(95 %)
11 diff
(98.7 %id)
CB990252 Human Placenta, placenta .a 71 to 796 21 to 759       739/797
(92 %)
33 diff
(95.9 %id)
CF593667 Human Placenta, placenta .a 71 to 829 22 to 782       761/798
(95 %)
17 diff
(97.9 %id)
DA086197 cerebellum .a 72 to 634 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA904879   .a 72 to 643 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA061654 cerebellum .a 79 to 606 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DA392092 thalamus .a 79 to 672 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
DA399641 thalamus .a 79 to 630 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA444734 tongue, tumor tissue .a 79 to 648 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA472777   .a 79 to 655 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DA482712   .a 79 to 652 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA491350 brain .a 79 to 652 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA494876 brain .a 79 to 647 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA532035 brain .a 79 to 688 2 to 612   capped   611/611
(100 %)
2 diff
(99.7 %id)
DA557981   .a 79 to 647 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA593768 lung .a 79 to 645 2 to 570   capped   569/569
(100 %)
5 diff
(99.2 %id)
DB148709 thymus .a 79 to 639 2 to 564   capped   563/563
(100 %)
4 diff
(99.3 %id)
DA295648 hippocampus .a 80 to 642 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DA504136 brain .a 80 to 636 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BP253726 Kidney .a 80 to 660 1 to 581       581/582
(99 %)
7 diff
(98.8 %id)
DA645480   .a 80 to 651 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA655580   .a 80 to 652 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA777550 brain .a 80 to 650 2 to 572   capped   571/572
(99 %)
4 diff
(99.4 %id)
CB153005 brain .a 81 to 671 1 to 591       591/591
(100 %)
1 diff
(99.9 %id)
BP208650 cerebellum .a 81 to 662 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA600707   .a 81 to 650 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
CB127081 Liver .a 81 to 682 1 to 602       602/602
(100 %)
1 diff
(99.9 %id)
BP304891   .a 81 to 662 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA033279   .a 82 to 644 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA038225   .a 82 to 644 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA050195   .a 82 to 670 2 to 592   capped   591/591
(100 %)
2 diff
(99.7 %id)
DA128578 cerebellum .a 82 to 667 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA157736 amygdala .a 82 to 669 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA179096 amygdala .a 82 to 657 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA204660 brain .a 82 to 662 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA207236 brain .a 82 to 637 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA357114 subthalamic nucleus .a 82 to 652 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA371105 thalamus .a 82 to 653 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA438634 tongue, tumor tissue .a 82 to 659 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA440679 tongue, tumor tissue .a 82 to 669 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA444633 tongue, tumor tissue .a 82 to 652 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA446436 tongue, tumor tissue .a 82 to 652 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA447518 tongue, tumor tissue .a 82 to 655 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA464401   .a 82 to 625 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA475092   .a 82 to 631 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA502332 brain .a 82 to 612 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DA510828 brain .a 82 to 654 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA511217 brain .a 82 to 626 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA525591 brain .a 82 to 649 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA530067 brain .a 82 to 679 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DA554156   .a 82 to 636 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA575244   .a 82 to 657 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA579613   .a 82 to 641 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BP262568 small intestine .a 82 to 656 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
DA598015   .a 82 to 636 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA650507   .a 82 to 639 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA655265   .a 82 to 645 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA666587   .a 82 to 643 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA729899   .a 82 to 834 2 to 753   capped   752/752
(100 %)
4 diff
(99.5 %id)
DA738419   .a 82 to 886 2 to 807   capped   806/808
(99 %)
4 diff
(99.6 %id)
DA741908   .a 82 to 647 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA741976   .a 82 to 630 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA762787 tongue .a 82 to 644 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA771712 brain .a 82 to 652 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA774254 brain .a 82 to 652 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA776875 brain .a 82 to 651 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA817138   .a 82 to 650 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA912752   .a 82 to 641 2 to 561   capped   560/561
(99 %)
1 diff
(99.9 %id)
DA924647 small intestine .a 82 to 653 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA933296 Spleen .a 82 to 645 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
DA942025 Spleen .a 82 to 667 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA992531 synovial membrane tissue from rheumatioidarthritis .a 82 to 615 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DB048697 testis .a 82 to 657 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DB109362 thymus .a 82 to 643 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DB152033 thymus .a 82 to 683 2 to 604   capped   603/603
(100 %)
2 diff
(99.7 %id)
DB160943 thymus .a 82 to 653 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB163366 thymus .a 82 to 641 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB164328 thymus .a 82 to 665 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DB164577 thymus .a 82 to 659 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DB204386 trachea .a 82 to 634 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA420148 cord Blood .a 85 to 657 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
TI_45235610   .a 86 to 809 65 to 789       725/1036
(69 %)
12 diff
(98.9 %id)
BI517364 pooled colon, kidney, stomach .a 91 to 809 1 to 720       720/967
(74 %)
6 diff
(99.4 %id)
BU849678 ovary, teratocarcinoma, cell line .a 93 to 945 1 to 861       861/863
(99 %)
10 diff
(98.9 %id)
BU855573 ovary, teratocarcinoma, cell line .a 93 to 846 1 to 758       758/880
(86 %)
5 diff
(99.5 %id)
BX375641 Neuroblastoma Cot 25-normalized .a 95 to 1092 1 to 995       995/995
(100 %)
7 diff
(99.3 %id)
CX166615 human embryonic stem cells differentiated toan early endodermal cell type .a 100 to 915 1 to 816       816/816
(100 %)
0 diff
(100 %id)
TI_154186769   .a 106 to 941 47 to 875       829/1011
(81 %)
14 diff
(98.7 %id)
CF125243 Chondrosarcoma Lung Metastasis cell lines, lung .a 107 to 808 1 to 701       701/701
(100 %)
3 diff
(99.6 %id)
DA201236 brain .a 109 to 659 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
TI_57232279   .a 110 to 686 11 to 620       570/640
(89 %)
27 diff
(95.8 %id)
DB133970 thymus .a 110 to 651 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA201619 brain .a 111 to 630 2 to 521   capped   520/520
(100 %)
0 diff
(100 %id)
DA287498 corpus callosum .a 111 to 679 2 to 570   capped   569/570
(99 %)
2 diff
(99.7 %id)
CA489176   .a 111 to 846 1 to 744       744/869
(85 %)
11 diff
(98.8 %id)
BC027603 testis .a 122 to 2898 1 to 2777   available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2777/2779
(99 %)
11 diff
(99.7 %id)
BG717589 testis .a 122 to 681 1 to 560       560/560
(100 %)
5 diff
(99.2 %id)
TI_57233522   .a 191 to 1093 18 to 910       891/910
(97 %)
30 diff
(96.8 %id)
CX785681 human embryonic stem cells .a 198 to 1039 1 to 842       842/842
(100 %)
0 diff
(100 %id)
DB362787   .a 2452 to 2896 445 to 1       445/446
(99 %)
3 diff
(99.4 %id)
AK127440 thalamus .b 1 to 2385 1 to 2386 A62V tiling clone, available from FLJ,   2386/2386
(100 %)
5 diff
(99.8 %id)
DA392167 thalamus .b 2 to 574 2 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
ES311960 frontal balding hair, skin .b 5 to 107 1 to 101       101/112
(90 %)
3 diff
(97.4 %id)
BI260540 cervical carcinoma cell line, cervix .b 7 to 62 1 to 56       56/56
(100 %)
0 diff
(100 %id)
ES312432 frontal balding hair, skin .b 15 to 209 1 to 192       192/192
(100 %)
3 diff
(98.5 %id)
AU076884   .b 24 to 184 1 to 160       160/160
(100 %)
6 diff
(96.3 %id)
ES315178 occipital scalp hair, skin .b 30 to 209 1 to 177       177/177
(100 %)
4 diff
(97.8 %id)
BM740491 stomach .b 41 to 204 1 to 166       166/166
(100 %)
7 diff
(95.8 %id)
DB456052 testis .b 45 to 201 1 to 157       157/157
(100 %)
0 diff
(100 %id)
BX353163 Neuroblastoma Cot 25-normalized .b 276 to 1343 1 to 1060   tiling clone,   1060/1066
(99 %)
18 diff
(98.4 %id)
CD672698 eye, Iris .b 352 to 876 1 to 525       525/525
(100 %)
0 diff
(100 %id)
AA078462 placenta .b 378 to 649 1 to 272       272/272
(100 %)
0 diff
(100 %id)
G30869   .b 378 to 649 1 to 272       272/272
(100 %)
0 diff
(100 %id)
BP211001 cerebellum .b 546 to 1126 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DA038491   .b 664 to 1224 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BX410240 adult brain, brain .b 684 to 1476 1 to 793       793/793
(100 %)
9 diff
(98.9 %id)
BX410239 adult brain, brain .b 686 to 1481 1 to 793       793/793
(100 %)
5 diff
(99.4 %id)
BG419575 Kidney, renal cell adenocarcinoma .b 712 to 1429 1 to 717       717/758
(94 %)
15 diff
(98.1 %id)
BM696002 eye, human retina .b 736 to 1327 1 to 592       592/592
(100 %)
0 diff
(100 %id)
TI_151700668   .b 738 to 1478 781 to 45       737/1016
(72 %)
22 diff
(97.9 %id)
DA730550   .b 757 to 1555 2 to 798   capped   797/805
(99 %)
8 diff
(99.1 %id)
BQ722285 sympathetic trunk .b 758 to 1476 12 to 731       720/933
(77 %)
17 diff
(98.2 %id)
AW003105 pooled germ cell tumors .b 808 to 1478 671 to 1       671/692
(96 %)
4 diff
(99.5 %id)
TI_151750011   .b 822 to 1478 734 to 78   tiling clone,   657/871
(75 %)
1 diff
(99.9 %id)
BM705191 eye, RPE and Choroid .b 823 to 1402 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
AA336368 endometrium .b 826 to 1121 1 to 296       296/296
(100 %)
0 diff
(100 %id)
TI_151707065   .b 895 to 1478 629 to 46       584/1005
(58 %)
0 diff
(100 %id)
BM708283 eye, RPE and Choroid .b 896 to 1425 1 to 530       530/530
(100 %)
0 diff
(100 %id)
AI017874 pooled .b 949 to 1478 530 to 1       530/530
(100 %)
0 diff
(100 %id)
AI870655 anaplastic oligodendroglioma, brain .b 1012 to 1460 449 to 1       449/449
(100 %)
0 diff
(100 %id)
AI208359   .b 1050 to 1444 395 to 1       395/395
(100 %)
0 diff
(100 %id)
BP204754 coronary artery .b 1078 to 1658 1 to 581       581/581
(100 %)
0 diff
(100 %id)
AI278571 carcinoid, lung .b 1090 to 1478 389 to 1       389/389
(100 %)
0 diff
(100 %id)
AI223453   .b 1098 to 1444 347 to 1       347/347
(100 %)
0 diff
(100 %id)
AI684799 pooled .b 1123 to 1315 193 to 1       193/205
(94 %)
12 diff
(94.2 %id)
AW614365 Kidney .b 1129 to 1460 332 to 1       332/332
(100 %)
0 diff
(100 %id)
BE795104 lung, small cell carcinoma .b 1151 to 1965 1 to 804       804/1002
(80 %)
23 diff
(97.8 %id)
AW470721 2 pooled tumors (clear cell type), Kidney .b 1162 to 1478 317 to 1       317/317
(100 %)
0 diff
(100 %id)
BU931088 ovary, teratocarcinoma, cell line .b 1217 to 2105 1 to 901       901/927
(97 %)
18 diff
(98.1 %id)
TI_154169317   .b 1250 to 1746 79 to 575       497/498
(99 %)
2 diff
(99.6 %id)
AA290592 germinal center B cell .b 1471 to 2001 1 to 524     Submitted on the opposite strand 524/525
(99 %)
7 diff
(98.7 %id)
AA281577 germinal center B cell .b 1471 to 1742 1 to 269     Submitted on the opposite strand 269/269
(100 %)
8 diff
(97.1 %id)
AW027265 thymus, pooled .b 1471 to 2081 1 to 611   tiling clone, Submitted on the opposite strand 611/611
(100 %)
0 diff
(100 %id)
R73848 placenta .b 1490 to 1917 1 to 439     Submitted on the opposite strand 439/439
(100 %)
18 diff
(95.9 %id)
AA375407 lung .b 1495 to 1826 1 to 332       332/332
(100 %)
0 diff
(100 %id)
AW149403 brain, medulloblastoma .b 1501 to 1981 1 to 481     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
ES315484 occipital scalp hair, skin .b 1588 to 1748 1 to 161       161/161
(100 %)
1 diff
(99.4 %id)
FN048223 breast carcinoma .b 2037 to 2119 1 to 84       84/84
(100 %)
1 diff
(98.9 %id)
DB311829 thalamus .b 2326 to 2852 532 to 4   tiling clone,   529/532
(99 %)
0 diff
(100 %id)
DC304654 cerebellum .c 1 to 568 1 to 572   tiling clone,   572/572
(100 %)
4 diff
(99.4 %id)
NM_001142936.1   .c 1 to 2523 1 to 2523 exact RefSeq,   2523/2523
(100 %)
0 diff
(100 %id)
DC303993 cerebellum .c 15 to 586 1 to 572       572/572
(100 %)
0 diff
(100 %id)
DC302095   .c 16 to 440 1 to 426       426/426
(100 %)
3 diff
(99.3 %id)
DC316244 amygdala .c 27 to 530 1 to 504       504/504
(100 %)
0 diff
(100 %id)
DW420307 Liver .c 27 to 310 18 to 301       284/301
(94 %)
8 diff
(97.4 %id)
DC375638 brain .c 27 to 491 1 to 466       466/466
(100 %)
2 diff
(99.6 %id)
DC376102 brain .c 27 to 563 1 to 537       537/537
(100 %)
0 diff
(100 %id)
DC357849   .c 34 to 589 1 to 557       557/557
(100 %)
3 diff
(99.5 %id)
DC338123 subthalamic nucleus .c 42 to 593 1 to 552   tiling clone,   552/552
(100 %)
0 diff
(100 %id)
DC396313 testis .c 47 to 582 1 to 536       536/536
(100 %)
1 diff
(99.9 %id)
BM147961 leukopheresis .c 58 to 365 1 to 308       308/308
(100 %)
14 diff
(95.5 %id)
DA083365 cerebellum .c 60 to 541 2 to 483   capped   482/482
(100 %)
0 diff
(100 %id)
DA744629   .c 60 to 582 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
DB141778 thymus .c 60 to 530 2 to 472   capped   471/471
(100 %)
0 diff
(100 %id)
DA719567   .c 62 to 541 2 to 481   capped   480/480
(100 %)
0 diff
(100 %id)
DW408691 Liver .c 66 to 399 9 to 342       334/342
(97 %)
8 diff
(97.7 %id)
AK298955   .c 78 to 2122 1 to 2045   tiling clone,   2045/2045
(100 %)
1 diff
(100.0 %id)
DC368017   .c 78 to 636 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
DA791482 brain .c 79 to 368 2 to 291   capped   290/290
(100 %)
0 diff
(100 %id)
DC301483   .c 81 to 679 1 to 600       600/600
(100 %)
1 diff
(99.9 %id)
DC302630 cerebellum .c 81 to 659 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
BP280717   .c 81 to 663 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA214486 brain .c 82 to 483 2 to 403   capped   402/402
(100 %)
0 diff
(100 %id)
DA295692 hippocampus .c 82 to 582 2 to 502   capped   501/501
(100 %)
0 diff
(100 %id)
DB078067 testis .c 82 to 571 2 to 491   capped   490/490
(100 %)
0 diff
(100 %id)
BM151801 leukopheresis .c 106 to 475 1 to 370       370/370
(100 %)
9 diff
(97.6 %id)
BE247283 leukopheresis .c 106 to 425 1 to 320       320/320
(100 %)
4 diff
(98.8 %id)
AK074210   .c 732 to 2513 1 to 1782   available from FLJ, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 1782/1782
(100 %)
3 diff
(99.9 %id)
F11269 brain, total brain .c 975 to 1286 1 to 312       312/312
(100 %)
2 diff
(99.4 %id)
W95017 liver and spleen .c 1404 to 2042 1 to 641       641/641
(100 %)
10 diff
(98.5 %id)
BQ881748 brain, neuroblastoma, cell line .c 1507 to 2225 1 to 736       736/898
(81 %)
20 diff
(97.8 %id)
TI_227714125   .c 1606 to 2509 975 to 87   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 889/981
(90 %)
24 diff
(97.6 %id)
BM769482 stomach .c 1619 to 2262 1 to 643       643/643
(100 %)
5 diff
(99.3 %id)
TI_159711922   .c 1633 to 2509 947 to 91   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 857/1029
(83 %)
20 diff
(98.1 %id)
TI_227712988   .c 1723 to 2510 899 to 122       778/1051
(74 %)
0 diff
(100 %id)
TI_149314485   .c 1733 to 2509 870 to 99   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 772/959
(80 %)
20 diff
(98.0 %id)
TI_151742461   .c 1759 to 2513 871 to 111   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 761/976
(77 %)
62 diff
(93.7 %id)
DB126644 thymus .c 1775 to 2292 2 to 519   capped   518/518
(100 %)
0 diff
(100 %id)
TI_154048427   .c 1792 to 2509 813 to 101   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 713/936
(76 %)
11 diff
(98.9 %id)
AW963036   .c 1815 to 2522 1 to 709   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 709/709
(100 %)
11 diff
(98.5 %id)
CB306119 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1819 to 2509 709 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 691/691
(100 %)
7 diff
(99.0 %id)
BM923422 pooled colon, kidney, stomach .c 1820 to 2509 19 to 708   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 690/708
(97 %)
5 diff
(99.3 %id)
CD367345 Alveolar Macrophage, lung .c 1823 to 2510 705 to 18       688/705
(97 %)
0 diff
(100 %id)
BU625564 cell lines, Enchondroma .c 1826 to 2509 701 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 683/683
(100 %)
4 diff
(99.5 %id)
CB852184 Human Lung Epithelial cells, lung .c 1852 to 2509 675 to 17   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 659/659
(100 %)
4 diff
(99.4 %id)
CD364848 Alveolar Macrophage, lung .c 1866 to 2509 660 to 17   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 644/644
(100 %)
4 diff
(99.4 %id)
CA426811 cell lines, Chondrosarcoma .c 1874 to 2509 652 to 17   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 636/636
(100 %)
0 diff
(100 %id)
BQ019226 lung, Metastatic Chondrosarcoma .c 1880 to 2509 646 to 17   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 630/630
(100 %)
1 diff
(99.9 %id)
CB528359 Aveolar Macrophage, lung .c 1880 to 2513 653 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 635/635
(100 %)
3 diff
(99.6 %id)
BM707252 eye, eye anterior segment .c 1950 to 2509 3 to 562   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 560/562
(99 %)
6 diff
(99.0 %id)
EC534473 Prostate .c 1965 to 2061 1 to 97       97/97
(100 %)
0 diff
(100 %id)
BM663251 eye, RPE and Choroid .c 2030 to 2509 497 to 18   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 480/480
(100 %)
0 diff
(100 %id)
AI423164 brain, glioblastoma (pooled) .c 2109 to 2513 405 to 1   tiling clone,   405/405
(100 %)
0 diff
(100 %id)
W93155 liver and spleen .c 2112 to 2509 397 to 1       397/397
(100 %)
2 diff
(99.5 %id)
BM145188 leukopheresis .c 2161 to 2509 366 to 17   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 350/350
(100 %)
17 diff
(95.2 %id)
BM150526 leukopheresis .c 2201 to 2506 325 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 307/311
(98 %)
0 diff
(100 %id)
F08929 brain, total brain .c 2204 to 2509 306 to 1       306/306
(100 %)
1 diff
(99.7 %id)
BU728380 eye, eye anterior segment .c 2291 to 2509 235 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 219/219
(100 %)
2 diff
(99.1 %id)
CB133232 Liver .d 1 to 318 1 to 318   tiling clone,   318/318
(100 %)
1 diff
(99.7 %id)
CB139903 Liver .d 2 to 549 1 to 548       548/548
(100 %)
0 diff
(100 %id)
CB133772 Liver .d 2 to 537 1 to 536       536/536
(100 %)
1 diff
(99.9 %id)
CB137816 Liver .d 2 to 611 1 to 610   tiling clone,   610/610
(100 %)
0 diff
(100 %id)
CB133250 Liver .d 2 to 489 1 to 488       488/488
(100 %)
2 diff
(99.6 %id)
DC374180 brain .d 98 to 671 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
AK298910   .d 548 to 2527 1 to 1980 exact tiling clone,   1980/1980
(100 %)
0 diff
(100 %id)
DC367189   .d 548 to 1037 1 to 490       490/490
(100 %)
0 diff
(100 %id)
TI_57162351   .e 1 to 738 28 to 766   tiling clone,   739/766
(96 %)
7 diff
(99.1 %id)
BI832887 pooled pancreas and spleen .e 4 to 738 1 to 736       736/736
(100 %)
1 diff
(99.9 %id)
AK122748   .e 11 to 2272 1 to 2262 exact tiling clone, available from FLJ,   2262/2262
(100 %)
0 diff
(100 %id)
DA706472   .e 12 to 540 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
DB323999   .e 1742 to 2272 531 to 1       531/531
(100 %)
1 diff
(99.9 %id)
AK093958 trachea .f 1 to 2233 1 to 2233 L175V Q383R tiling clone, available from FLJ,   2233/2233
(100 %)
6 diff
(99.8 %id)
AX748382   .f 1 to 2233 1 to 2233 L175V Q383R     2233/2233
(100 %)
6 diff
(99.8 %id)
DB206656 trachea .f 2 to 569 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB348631 trachea .f 1689 to 2233 547 to 1       547/547
(100 %)
5 diff
(99.1 %id)
AK091228 tongue, tumor tissue .g 1 to 2589 1 to 2590 M342V tiling clone, available from FLJ,   2590/2590
(100 %)
8 diff
(99.7 %id)
AX746862   .g 1 to 2589 1 to 2590 M342V     2590/2590
(100 %)
8 diff
(99.7 %id)
DA440080 tongue, tumor tissue .g 2 to 581 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
CB153474 brain .g 103 to 666 1 to 564       564/564
(100 %)
3 diff
(99.5 %id)
TI_154002679   .g 638 to 1208 633 to 63       571/633
(90 %)
5 diff
(99.3 %id)
AA573351 colon .g 690 to 1208 516 to 1       516/516
(100 %)
8 diff
(98.5 %id)
AI334429 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 709 to 1208 497 to 1       497/497
(100 %)
7 diff
(98.6 %id)
AW170515 cervix, tumor .g 710 to 1162 465 to 13       453/465
(97 %)
5 diff
(99.0 %id)
AI143687 anaplastic oligodendroglioma, brain .g 717 to 1190 474 to 1       474/474
(100 %)
4 diff
(99.2 %id)
AW000849 colon, colonic mucosa from 3 patients with Crohn'sdisease .g 798 to 1162 367 to 1       367/367
(100 %)
3 diff
(99.2 %id)
AA514288 colon .g 970 to 1174 204 to 1       204/204
(100 %)
1 diff
(99.6 %id)
DB313645 tongue, tumor tissue .g 2045 to 2589 546 to 1   tiling clone,   546/546
(100 %)
4 diff
(99.3 %id)
AI968096 pooled germ cell tumors .h 1 to 437 437 to 1   tiling clone,   437/437
(100 %)
0 diff
(100 %id)
BF514443   .h 431 to 858 1 to 428   tiling clone, Submitted on the opposite strand 428/437
(97 %)
1 diff
(99.8 %id)
H14057 brain .h 437 to 862 1 to 440     Submitted on the opposite strand 440/443
(99 %)
25 diff
(94.4 %id)
AA937978 germinal center B cell .h 505 to 903 1 to 399   tiling clone, Submitted on the opposite strand 399/399
(100 %)
1 diff
(99.8 %id)
DC327846 caudate nucleus .i 1 to 580 1 to 580   tiling clone,   580/580
(100 %)
0 diff
(100 %id)
DC297767   .i 23 to 460 1 to 440       440/440
(100 %)
6 diff
(98.7 %id)
AK301104 Spleen .i 23 to 1396 1 to 1374 exact tiling clone,   1374/1374
(100 %)
4 diff
(99.8 %id)
DC389777 Spleen .i 23 to 487 1 to 465       465/465
(100 %)
0 diff
(100 %id)
N57348 placenta .i 1283 to 1717 1 to 431   tiling clone,   431/436
(98 %)
11 diff
(97.5 %id)
N29417 placenta .i 2437 to 2648 217 to 7   tiling clone,   211/217
(97 %)
0 diff
(100 %id)
AK090943 amygdala .j 1 to 2377 2 to 2377 exact tiling clone, available from FLJ,   2377/2377
(100 %)
4 diff
(99.9 %id)
AX746695   .j 1 to 2377 2 to 2377 exact     2377/2377
(100 %)
4 diff
(99.9 %id)
DA161694 amygdala .j 1 to 447 2 to 448   capped   447/447
(100 %)
1 diff
(99.8 %id)
DB302180 amygdala .j 1822 to 2377 556 to 1       556/556
(100 %)
0 diff
(100 %id)
CR607926 Neuroblastoma Cot 25-normalized .k 1 to 1152 1 to 1152 exact tiling clone,   1152/1152
(100 %)
0 diff
(100 %id)
BX364610 Neuroblastoma Cot 25-normalized .k 1 to 1052 1 to 1051 I23X I138X     1051/1051
(100 %)
15 diff
(98.6 %id)
NM_006854.3   .k 25 to 2883 1 to 2859 exact RefSeq, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2859/2859
(100 %)
0 diff
(100 %id)
DA886315   .k 26 to 581 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
AL527895 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .k 36 to 1130 31 to 1114 exact     1084/1134
(95 %)
36 diff
(96.9 %id)
TI_44167551   .k 44 to 802 79 to 838       758/842
(90 %)
8 diff
(99.1 %id)
CR617298 Placenta Cot 25-normalized .k 48 to 1202 1 to 1155 exact     1155/1155
(100 %)
0 diff
(100 %id)
AK315702 testis .k 53 to 824 1 to 772 exact     772/772
(100 %)
0 diff
(100 %id)
DB454924 testis .k 53 to 543 1 to 491       491/491
(100 %)
1 diff
(99.8 %id)
CB960116 Human Placenta, placenta .k 53 to 649 28 to 635       608/770
(78 %)
26 diff
(96.7 %id)
AU129694   .k 53 to 738 2 to 695   fully sequenced, capped   694/694
(100 %)
10 diff
(98.6 %id)
DA663077   .k 54 to 619 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
AU127431   .k 54 to 739 2 to 689   capped   688/690
(99 %)
13 diff
(98.2 %id)
AU131526   .k 54 to 853 2 to 802 V185I C192X F195Y S209N capped   801/806
(99 %)
7 diff
(99.2 %id)
DA914540   .k 54 to 552 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
DB002091 breast, tumor tissue .k 54 to 570 2 to 518   capped   517/517
(100 %)
0 diff
(100 %id)
DB073046 testis .k 54 to 601 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
AU118515 whole embryo, mainly head .k 56 to 705 2 to 651   fully sequenced, capped   650/650
(100 %)
1 diff
(99.9 %id)
DA777987 brain .k 57 to 619 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA743183   .k 62 to 581 2 to 521   capped   520/520
(100 %)
0 diff
(100 %id)
AL547016 placenta, Placenta Cot 25-normalized .k 64 to 567 17 to 520   fully sequenced,   504/520
(96 %)
6 diff
(98.9 %id)
BX364609 Neuroblastoma Cot 25-normalized .k 66 to 1141 1080 to 6 T26D R27A S28L C29L A30R ...     1075/1080
(99 %)
7 diff
(99.4 %id)
BM905303 melanotic melanoma, skin .k 66 to 1022 1 to 961 K207E L208A S209Q L210F P211A ...     961/1019
(94 %)
19 diff
(98.2 %id)
CR625485 B cells (Ramos cell line) Cot 25-normalized .k 68 to 1065 1 to 998 exact     998/998
(100 %)
0 diff
(100 %id)
AL561557 B cells from Burkitt lymphoma .k 68 to 1062 1 to 989 exact fully sequenced,   989/989
(100 %)
10 diff
(99.0 %id)
BM451445 eye, retinoblastoma .k 73 to 972 1 to 904 exact     904/1021
(88 %)
11 diff
(99.0 %id)
DA700246   .k 75 to 561 2 to 488   capped   487/487
(100 %)
0 diff
(100 %id)
DA702310   .k 75 to 552 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
AU131560   .k 75 to 760 2 to 687   capped   686/686
(100 %)
2 diff
(99.8 %id)
DB263214 uterus .k 75 to 579 2 to 506   capped   505/505
(100 %)
0 diff
(100 %id)
TI_45213569   .k 78 to 789 125 to 843       719/957
(75 %)
15 diff
(98.5 %id)
TI_44342865   .k 78 to 844 128 to 892 I189S L190Y Y191T C192V D193T ...     765/892
(85 %)
12 diff
(98.7 %id)
TI_44344477   .k 78 to 888 79 to 887 D193*     809/895
(90 %)
13 diff
(98.6 %id)
DA371562 thalamus .k 80 to 699 2 to 621   capped   620/620
(100 %)
0 diff
(100 %id)
DA786339 brain .k 80 to 657 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
AL527894 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .k 82 to 1143 1055 to 1 D9T L10C S11P H12T L13W ...     1055/1083
(97 %)
24 diff
(97.8 %id)
BM923364 pooled colon, kidney, stomach .k 83 to 1026 11 to 960 K201Q K204Q K207E L208A S209Q ...     950/1073
(88 %)
32 diff
(97.1 %id)
TI_57147962   .k 85 to 882 68 to 868 K206T K207E L208A S209Q L210F ...     801/871
(91 %)
12 diff
(98.7 %id)
TI_57176345   .k 85 to 898 28 to 842 exact     815/842
(96 %)
7 diff
(99.2 %id)
TI_44172014   .k 85 to 842 121 to 886 I189N L190P Y191I C192L D193*     766/960
(79 %)
21 diff
(97.9 %id)
DA719248   .k 86 to 581 2 to 497   capped   496/496
(100 %)
0 diff
(100 %id)
AW163331 brain, frontal lobe .k 87 to 507 1 to 419       419/419
(100 %)
3 diff
(99.3 %id)
BC012994 Uterus, endometrium adenocarcinoma .k 90 to 1177 1 to 1088 M137V available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 1088/1088
(100 %)
2 diff
(99.9 %id)
AU130994   .k 90 to 855 2 to 767 I189X S209N P211X capped   766/771
(99 %)
9 diff
(98.9 %id)
TI_154190021   .k 91 to 932 51 to 885 A212S     835/980
(85 %)
14 diff
(98.6 %id)
BQ689782 ductal carcinoma, cell line, Pancreas .k 92 to 1022 1 to 947 C192W     947/954
(99 %)
37 diff
(96.2 %id)
DB505560 hypothalamus .k 94 to 552 1 to 459       459/459
(100 %)
1 diff
(99.8 %id)
DA628774 Kidney .k 95 to 657 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA652202   .k 95 to 581 2 to 488   capped   487/487
(100 %)
0 diff
(100 %id)
DA684821   .k 95 to 550 2 to 457   capped   456/456
(100 %)
0 diff
(100 %id)
DA705059   .k 95 to 586 2 to 493   capped   492/492
(100 %)
0 diff
(100 %id)
DA764993 tongue .k 95 to 552 2 to 459   capped   458/458
(100 %)
0 diff
(100 %id)
AU135528 placenta .k 95 to 787 2 to 697   capped   696/696
(100 %)
11 diff
(98.5 %id)
DA850224 placenta .k 95 to 633 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA973964 synovial membrane tissue from rheumatioidarthritis .k 95 to 649 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB259444 uterus .k 95 to 652 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA716615   .k 97 to 577 2 to 482   capped   481/481
(100 %)
0 diff
(100 %id)
DA663557   .k 104 to 663 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB473029 hippocampus .k 105 to 573 1 to 469       469/469
(100 %)
0 diff
(100 %id)
CR601220 placenta .k 108 to 2188 1 to 2081 exact tiling clone,   2081/2081
(100 %)
0 diff
(100 %id)
AL542254 placenta .k 108 to 1135 1 to 1024 exact fully sequenced,   1024/1024
(100 %)
5 diff
(99.6 %id)
BI524084 pooled lung and spleen .k 110 to 1035 1 to 931 L210F P211A A212S     931/933
(99 %)
37 diff
(96.1 %id)
DB476893 hippocampus .k 113 to 615 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
BM762319 myeloma .k 113 to 700 1 to 588       588/588
(100 %)
0 diff
(100 %id)
CR595066 B cells (Ramos cell line) Cot 25-normalized .k 117 to 1769 1 to 1653 exact     1653/1653
(100 %)
0 diff
(100 %id)
AL583441 B cells from Burkitt lymphoma .k 117 to 1174 1 to 1042 exact     1042/1042
(100 %)
17 diff
(98.4 %id)
CA975916 sciatic nerve .k 120 to 1013 12 to 911 K201X K204Q K207E L208A S209Q ...     900/911
(98 %)
22 diff
(97.6 %id)
BC008081 Skin, melanotic melanoma. .k 121 to 1249 1 to 1129 exact available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 1129/1131
(99 %)
2 diff
(99.9 %id)
AL556715 placenta .k 121 to 1164 1 to 1036 L161X     1036/1042
(99 %)
16 diff
(98.5 %id)
AL548730 placenta, Placenta Cot 25-normalized .k 123 to 866 1 to 744 exact     744/744
(100 %)
1 diff
(99.9 %id)
BM922068 pooled brain, lung, testis .k 135 to 1022 1 to 895 exact     895/1027
(87 %)
12 diff
(98.9 %id)
BC014568 Bone marrow, chronic myelogenous leukemia .k 137 to 1243 303 to 1409 exact AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 1107/1411
(78 %)
8 diff
(99.5 %id)
BX324872 Placenta Cot 25-normalized .k 140 to 1033 1 to 894 K81X     894/894
(100 %)
4 diff
(99.6 %id)
BM822434 stomach .k 140 to 558 1 to 419       419/419
(100 %)
0 diff
(100 %id)
X63745 placenta .k 174 to 860 1 to 688 exact     688/688
(100 %)
3 diff
(99.6 %id)
M88458   .k 183 to 1326 36 to 1180 exact     1145/1180
(97 %)
10 diff
(99.2 %id)
TI_1948090354   .k 185 to 818 131 to 764   fully sequenced,   634/764
(82 %)
7 diff
(99.1 %id)
TI_1948144913   .k 185 to 823 767 to 129       639/1237
(51 %)
2 diff
(99.9 %id)
TI_1948145621   .k 185 to 823 771 to 129       643/1367
(47 %)
21 diff
(98.5 %id)
DB266226 uterus .k 192 to 779 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA627642 Kidney .k 196 to 718 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
BU193485 eye, retinoblastoma .k 230 to 1163 1 to 936       936/939
(99 %)
15 diff
(98.5 %id)
BY996996   .k 234 to 870 10 to 646       637/646
(98 %)
7 diff
(99.0 %id)
DA378160 thalamus .k 244 to 745 2 to 503   capped   502/502
(100 %)
0 diff
(100 %id)
CR625166 placenta .k 319 to 1248 1 to 930       930/930
(100 %)
0 diff
(100 %id)
TI_149284170   .k 330 to 1093 842 to 85   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 760/806
(94 %)
12 diff
(98.6 %id)
AL582731 B cells from Burkitt lymphoma .k 347 to 1065 720 to 1   fully sequenced,   720/720
(100 %)
7 diff
(99.1 %id)
AU136168 placenta .k 354 to 1200 2 to 862   capped   861/866
(99 %)
21 diff
(97.6 %id)
AU139998 placenta .k 362 to 966 2 to 610   capped   609/609
(100 %)
4 diff
(99.4 %id)
AU134761 placenta .k 367 to 1082 2 to 727   capped   726/772
(94 %)
15 diff
(98.1 %id)
BM557847 astrocytoma grade IV, cell line, brain .k 368 to 1281 1 to 925       925/1082
(85 %)
21 diff
(98.1 %id)
DA380265 thalamus .k 371 to 915 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA882980   .k 372 to 935 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
TI_227712802   .k 372 to 1245 939 to 82   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 858/963
(89 %)
27 diff
(97.2 %id)
CR615882 Placenta Cot 25-normalized .k 375 to 1095 1 to 721       721/721
(100 %)
0 diff
(100 %id)
AL552564 placenta, Placenta Cot 25-normalized .k 375 to 1095 1 to 721   fully sequenced,   721/721
(100 %)
0 diff
(100 %id)
CR605592 Neuroblastoma Cot 10-normalized .k 377 to 1101 1 to 725       725/725
(100 %)
0 diff
(100 %id)
BX352772 Neuroblastoma Cot 10-normalized .k 377 to 1101 1 to 725   fully sequenced,   725/725
(100 %)
1 diff
(99.9 %id)
BF034515 adenocarcinoma, ovary .k 378 to 1116 1 to 732       732/925
(79 %)
17 diff
(98.2 %id)
DB000784 breast, tumor tissue .k 383 to 920 2 to 540   capped   539/540
(99 %)
2 diff
(99.7 %id)
CF121151 CNCAP(3)T-225 cell line, Prostate .k 384 to 1081 1 to 698       698/698
(100 %)
5 diff
(99.3 %id)
BU167433 leiomyosarcoma, uterus .k 386 to 1243 1 to 870       870/899
(96 %)
21 diff
(97.7 %id)
TI_154180153   .k 390 to 1235 75 to 914       840/841
(99 %)
20 diff
(97.7 %id)
BP253882 Kidney .k 393 to 974 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AA369912 Prostate .k 403 to 706 1 to 304       304/304
(100 %)
1 diff
(99.7 %id)
AW838286 leiomios .k 408 to 789 1 to 381       381/381
(100 %)
1 diff
(99.8 %id)
TI_154116898   .k 408 to 1177 868 to 98   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 771/999
(77 %)
5 diff
(99.5 %id)
BI335911 skin .k 412 to 789 1 to 378       378/379
(99 %)
2 diff
(99.5 %id)
DA699333   .k 429 to 946 2 to 522   capped   521/521
(100 %)
5 diff
(99.1 %id)
BG109923 Bone, osteosarcoma, cell line .k 432 to 1156 1 to 731       731/943
(77 %)
19 diff
(98.0 %id)
AA356845   .k 436 to 757 1 to 322       322/322
(100 %)
2 diff
(99.4 %id)
CD519310 White Matter .k 439 to 1274 18 to 857       840/938
(89 %)
13 diff
(98.7 %id)
CD513881 brain, Pituitary .k 441 to 1281 1 to 844       844/880
(95 %)
9 diff
(99.0 %id)
DA699232   .k 441 to 979 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
BQ436464 melanotic melanoma, skin .k 447 to 1124 1 to 689       689/833
(82 %)
21 diff
(97.5 %id)
BM271819 Pancreas, Purified pancreatic islet .k 448 to 1031 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
CB127570 cervix, Uterine .k 475 to 939 1 to 465       465/465
(100 %)
3 diff
(99.4 %id)
BG423284 Kidney, renal cell adenocarcinoma .k 479 to 1135 1 to 653       653/655
(99 %)
8 diff
(98.8 %id)
BM722091 eye, fetal eye .k 493 to 1105 1 to 611     Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 611/611
(100 %)
6 diff
(99.1 %id)
BU680360 lung, Primary Lung Epithelial Cells .k 496 to 1093 616 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 598/598
(100 %)
1 diff
(99.9 %id)
CA449649 Chondrosarcoma, Left Pelvis .k 501 to 1177 695 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 677/677
(100 %)
1 diff
(99.9 %id)
BX352771 Neuroblastoma Cot 10-normalized .k 506 to 1081 576 to 1   fully sequenced,   576/576
(100 %)
2 diff
(99.7 %id)
AL572133 placenta, Placenta Cot 25-normalized .k 506 to 1202 698 to 1   fully sequenced,   698/698
(100 %)
5 diff
(99.3 %id)
AL552535 placenta, Placenta Cot 25-normalized .k 506 to 1064 559 to 1   fully sequenced,   559/559
(100 %)
2 diff
(99.7 %id)
TI_1948090355   .k 506 to 823 439 to 122   fully sequenced,   318/345
(92 %)
1 diff
(99.8 %id)
DA379866 thalamus .k 510 to 1167 2 to 660   capped   659/659
(100 %)
3 diff
(99.6 %id)
CB241214 Human Lung Epithelial cells, lung .k 512 to 1245 750 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 732/735
(99 %)
3 diff
(99.6 %id)
CF130704 Chondrosarcoma Lung Metastasis cell lines, lung .k 518 to 1115 1 to 598   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 598/598
(100 %)
1 diff
(99.9 %id)
DA577585   .k 520 to 1066 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
BM465379 eye, retinoblastoma .k 522 to 1138 92 to 708       617/1314
(46 %)
25 diff
(98.1 %id)
BM826273 Ascites, stomach .k 538 to 1086 1 to 549       549/549
(100 %)
0 diff
(100 %id)
AW157531 brain, frontal lobe .k 540 to 1200 665 to 6       660/665
(99 %)
9 diff
(98.7 %id)
ES308971 occipital hair of pubic hypotrichosispatient, skin .k 544 to 1094 1 to 554       554/563
(98 %)
4 diff
(99.3 %id)
AA903767 pooled germ cell tumors .k 551 to 1326 778 to 1       778/851
(91 %)
19 diff
(97.8 %id)
BM992116 Bone, Subchondral Bone .k 552 to 1245 711 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 693/693
(100 %)
2 diff
(99.8 %id)
CD742841 Alveolar Macrophage, lung .k 552 to 1245 712 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 694/694
(100 %)
1 diff
(99.9 %id)
CN301038 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 558 to 901 1 to 344       344/344
(100 %)
1 diff
(99.8 %id)
BQ447192 Knee, Osteoarthritic Cartilage .k 561 to 1245 702 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 684/684
(100 %)
2 diff
(99.8 %id)
CA313494 Human Lung Epithelial cells, lung .k 563 to 1245 700 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 682/682
(100 %)
2 diff
(99.8 %id)
BP267091 thyroid .k 588 to 1165 1 to 578       578/578
(100 %)
2 diff
(99.7 %id)
CF146215 CNCAP(3)T-225 cell line, Prostate .k 607 to 1245 1 to 639   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 639/639
(100 %)
5 diff
(99.3 %id)
CF146261 CNCAP(3)T-225 cell line, Prostate .k 607 to 1245 1 to 639   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 639/639
(100 %)
5 diff
(99.3 %id)
TI_154178613   .k 614 to 1245 74 to 705   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 632/705
(89 %)
6 diff
(99.2 %id)
TI_154178669   .k 614 to 1245 81 to 712   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 632/712
(88 %)
6 diff
(99.2 %id)
BQ722413 sympathetic trunk .k 617 to 1514 1 to 903       903/924
(97 %)
23 diff
(97.6 %id)
CA422266 Bone, Enchondroma cell line .k 617 to 1245 647 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 629/629
(100 %)
0 diff
(100 %id)
CN301018 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 620 to 723 1 to 104       104/104
(100 %)
0 diff
(100 %id)
ES312106 frontal balding hair, skin .k 626 to 834 1 to 209       209/209
(100 %)
2 diff
(99.1 %id)
BI258758 cervical carcinoma cell line, cervix .k 637 to 1385 1 to 748       748/748
(100 %)
6 diff
(99.2 %id)
AU125417   .k 640 to 1417 2 to 780   capped   779/779
(100 %)
2 diff
(99.8 %id)
DA630886 Kidney .k 642 to 1217 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA682987   .k 644 to 1175 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
AA970799 colon, colon tumor .k 645 to 1116 471 to 1       471/471
(100 %)
1 diff
(99.8 %id)
BI829905 brain, medulla .k 652 to 1108 1 to 457   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 457/457
(100 %)
0 diff
(100 %id)
FN157933 breast carcinoma .k 657 to 725 68 to 1     Submitted on the opposite strand 68/69
(98 %)
1 diff
(98.6 %id)
BM083635 adenocarcinoma, Prostate .k 658 to 1231 1 to 574       574/574
(100 %)
1 diff
(99.9 %id)
DB203108 trachea .k 667 to 1249 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DB525691 testis .k 668 to 1091 1 to 424     Submitted on the opposite strand 424/426
(99 %)
2 diff
(99.6 %id)
BP334140 salivary gland .k 668 to 1251 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
DA960392 Spleen .k 669 to 1231 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
BP353334   .k 670 to 1251 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CN301013 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 672 to 1211 7 to 546       540/546
(98 %)
6 diff
(99.0 %id)
AI952528 normal epithelium, ovary .k 672 to 1093 445 to 24   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 422/422
(100 %)
2 diff
(99.6 %id)
AU145060 whole embryo, mainly head .k 675 to 1245 571 to 1   fully sequenced,   571/571
(100 %)
9 diff
(98.5 %id)
CR620529 placenta .k 680 to 1246 1 to 567       567/567
(100 %)
0 diff
(100 %id)
BY998830   .k 683 to 1248 1 to 567     Submitted on the opposite strand 567/570
(99 %)
2 diff
(99.7 %id)
BP420716 small intestine .k 692 to 1277 1 to 586     Submitted on the opposite strand 586/586
(100 %)
0 diff
(100 %id)
DA687969   .k 692 to 1214 2 to 525   capped   524/524
(100 %)
2 diff
(99.7 %id)
DA172829 amygdala .k 694 to 1256 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
CN301015 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 696 to 1093 1 to 398   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 398/398
(100 %)
0 diff
(100 %id)
BP268261 thyroid .k 696 to 1264 1 to 569       569/569
(100 %)
3 diff
(99.5 %id)
AU151771   .k 708 to 1245 537 to 1   fully sequenced,   537/537
(100 %)
6 diff
(98.9 %id)
AU125682   .k 711 to 1516 2 to 808   capped   807/807
(100 %)
3 diff
(99.7 %id)
DB000484 breast, tumor tissue .k 711 to 1216 2 to 507   capped   506/506
(100 %)
0 diff
(100 %id)
DB210897 trachea .k 711 to 1319 2 to 613   capped   612/612
(100 %)
4 diff
(99.4 %id)
AV695368 hepatocellular carcinoma .k 731 to 1153 1 to 418       418/418
(100 %)
4 diff
(99.1 %id)
AA187383   .k 734 to 1206 1 to 482       482/482
(100 %)
12 diff
(97.6 %id)
BM542267 melanotic melanoma, skin .k 736 to 1567 1 to 838       838/996
(84 %)
23 diff
(97.7 %id)
BI520331 brain, medulla .k 741 to 1093 1 to 353   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 353/353
(100 %)
0 diff
(100 %id)
DA987955 synovial membrane tissue from rheumatioidarthritis .k 742 to 1317 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
DA622830 Kidney .k 744 to 1335 2 to 595   capped   594/594
(100 %)
3 diff
(99.5 %id)
DB550566 hippocampus .k 749 to 1243 1 to 495     Submitted on the opposite strand 495/497
(99 %)
1 diff
(99.8 %id)
AA291574 ovarian tumor, ovary .k 750 to 1245 496 to 1       496/496
(100 %)
3 diff
(99.4 %id)
DA544951   .k 754 to 1314 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
AW471500 colon, moderately-differentiated adenocarcinoma .k 762 to 1246 485 to 1       485/485
(100 %)
2 diff
(99.6 %id)
DA019220   .k 768 to 1318 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DB541785 hippocampus .k 779 to 1243 1 to 465     Submitted on the opposite strand 465/467
(99 %)
1 diff
(99.8 %id)
AL542253 placenta .k 1105 to 2188 1082 to 1   fully sequenced,   1082/1082
(100 %)
22 diff
(98.0 %id)
AL573302 placenta, Placenta Cot 25-normalized .k 1365 to 2176 812 to 1       812/812
(100 %)
8 diff
(99.1 %id)
AA187251   .k 1779 to 2218 440 to 1       440/440
(100 %)
0 diff
(100 %id)
AL578913 placenta .k 1781 to 2821 1040 to 18   tiling clone,   1023/1049
(97 %)
0 diff
(100 %id)
BX324871 Placenta Cot 25-normalized .k 1895 to 2825 931 to 1       931/931
(100 %)
4 diff
(99.6 %id)
DB364293   .k 1951 to 2203 253 to 1       253/253
(100 %)
1 diff
(99.7 %id)
BM678672 eye, fetal eye .k 2265 to 2883 637 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 619/619
(100 %)
6 diff
(99.1 %id)
DB368597   .k 2345 to 2874 528 to 1       528/531
(99 %)
6 diff
(98.9 %id)
DB368560   .k 2359 to 2874 516 to 1       516/520
(99 %)
11 diff
(97.9 %id)
DB380633 placenta .k 2426 to 2883 457 to 1       457/461
(99 %)
7 diff
(98.5 %id)
DB372530 placenta .k 2444 to 2874 430 to 1       430/430
(100 %)
8 diff
(98.2 %id)
DB374619 placenta .k 2456 to 2880 425 to 1       425/427
(99 %)
3 diff
(99.3 %id)
DB368112   .k 2458 to 2874 417 to 1       417/419
(99 %)
2 diff
(99.6 %id)
BE156555 head_neck .l 1 to 607 69 to 590   tiling clone,   526/590
(89 %)
9 diff
(98.5 %id)
W32931 parathyroid gland, parathyroid tumor .l 486 to 722 1 to 239   tiling clone,   237/239
(99 %)
2 diff
(99.2 %id)
W35367 parathyroid gland, parathyroid tumor .l 1465 to 1817 359 to 1   tiling clone,   359/385
(93 %)
13 diff
(96.7 %id)
BF313847 brain, neuroblastoma .m 1 to 600 32 to 629 T8R A9R A11P A12* tiling clone,   598/915
(65 %)
21 diff
(97.8 %id)
NM_001100603.1   .n 1 to 2605 2 to 2606 exact RefSeq, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2606/2606
(100 %)
0 diff
(100 %id)
DB205495 trachea .n 26 to 319 2 to 295   tiling clone, capped   294/294
(100 %)
0 diff
(100 %id)
BM857077 stomach .n 28 to 462 1 to 435       435/435
(100 %)
0 diff
(100 %id)
DA638449 Liver .n 29 to 502 2 to 475   capped   474/474
(100 %)
0 diff
(100 %id)
DA679247   .n 29 to 493 2 to 466   capped   465/465
(100 %)
0 diff
(100 %id)
DA711541   .n 29 to 485 2 to 458   capped   457/457
(100 %)
0 diff
(100 %id)
DA713617   .n 29 to 502 2 to 475   capped   474/474
(100 %)
0 diff
(100 %id)
DA519313 brain .n 30 to 508 2 to 480   capped   479/479
(100 %)
0 diff
(100 %id)
BC071982 Brain, astrocytoma, grade IV .n 46 to 899 1 to 854 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 854/854
(100 %)
0 diff
(100 %id)
DB460259 testis .n 56 to 516 1 to 461       461/461
(100 %)
0 diff
(100 %id)
DA952606 Spleen .n 61 to 404 2 to 345   capped   344/346
(99 %)
1 diff
(99.8 %id)
BM798846 myeloma .n 66 to 509 1 to 444       444/444
(100 %)
0 diff
(100 %id)
DA715356   .n 69 to 496 2 to 429   capped   428/430
(99 %)
1 diff
(99.8 %id)
DA545870   .n 70 to 437 2 to 369   capped   368/368
(100 %)
0 diff
(100 %id)
DA865548 Prostate .n 70 to 370 2 to 302   capped   301/301
(100 %)
0 diff
(100 %id)
CN301041 embryonic stem cells, DMSO-treated H9 cellline .n 79 to 436 1 to 358       358/358
(100 %)
0 diff
(100 %id)
DB481743 hippocampus .n 80 to 496 1 to 417       417/417
(100 %)
0 diff
(100 %id)
BM785100 Ascites, stomach .n 82 to 493 1 to 412       412/412
(100 %)
0 diff
(100 %id)
DA545536   .n 506 to 1077 2 to 573   capped   572/572
(100 %)
5 diff
(99.2 %id)
AU135337 placenta .n 510 to 1282 10 to 791   capped   782/791
(98 %)
14 diff
(98.3 %id)
DB002069 breast, tumor tissue .n 510 to 1075 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
BQ007226 placenta .n 512 to 940 447 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 434/434
(100 %)
0 diff
(100 %id)
AI139418 uterus .n 522 to 1020 499 to 1       499/499
(100 %)
4 diff
(99.2 %id)
BG680766 skin, squamous cell carcinoma .n 529 to 1221 1 to 692       692/692
(100 %)
3 diff
(99.6 %id)
AU137058 placenta .n 534 to 1252 2 to 728   capped   727/730
(99 %)
19 diff
(97.4 %id)
BP267316 thyroid .n 536 to 1117 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
AU125161   .n 555 to 1350 2 to 797   capped   796/798
(99 %)
13 diff
(98.4 %id)
DA959916 Spleen .n 555 to 1097 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BM782282 myeloma .n 557 to 899 1 to 343   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 343/343
(100 %)
0 diff
(100 %id)
BP383428 ilea mucosa .n 579 to 1306 1 to 736       736/764
(96 %)
11 diff
(98.6 %id)
BP256583 Kidney .n 587 to 1169 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BM850351 stomach .n 597 to 966 1 to 370       370/370
(100 %)
0 diff
(100 %id)
TI_157601610   .n 623 to 1381 64 to 814     Submitted on the opposite strand 751/1034
(72 %)
18 diff
(98.3 %id)
AU120840 whole embryo, mainly body .n 632 to 1486 2 to 852   capped   851/853
(99 %)
11 diff
(98.8 %id)
BF984082 duodenal adenocarcinoma, cell line, small intestine .n 640 to 1361 1 to 720       720/837
(86 %)
9 diff
(99.0 %id)
DA690167   .n 646 to 1181 2 to 538   capped   537/537
(100 %)
2 diff
(99.7 %id)
AW582261 stomach .n 658 to 1198 545 to 7       539/545
(98 %)
0 diff
(100 %id)
BM824545 Ascites, stomach .n 658 to 1197 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
DA821676 pericardium .n 666 to 1243 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
BG250701 adenocarcinoma, cell line, Liver .n 687 to 1471 1 to 785       785/791
(99 %)
13 diff
(98.4 %id)
BI859840 breast, mammary adenocarcinoma, cell line .n 700 to 1458 1 to 761       761/762
(99 %)
13 diff
(98.3 %id)
TI_57188913   .n 700 to 1458 50 to 810       761/762
(99 %)
13 diff
(98.3 %id)
DA552580   .n 719 to 1303 2 to 587   capped   586/586
(100 %)
2 diff
(99.7 %id)
BX391056   .n 728 to 1491 1 to 764       764/764
(100 %)
24 diff
(96.9 %id)
CB122822 Liver .n 732 to 1322 1 to 591       591/591
(100 %)
4 diff
(99.4 %id)
BP261706 small intestine .n 738 to 1319 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP262192 small intestine .n 738 to 1310 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
DB274764 uterus .n 738 to 1236 2 to 500   capped   499/503
(99 %)
2 diff
(99.7 %id)
BP203008 coronary artery .n 741 to 1314 1 to 575       575/575
(100 %)
3 diff
(99.5 %id)
DA635275 Kidney .n 743 to 1335 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
DB243141 stomach, tumor tissue .n 743 to 1313 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BM728534 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .n 760 to 1470 1 to 711       711/711
(100 %)
2 diff
(99.8 %id)
DN920195   .n 768 to 1267 1 to 500       500/500
(100 %)
1 diff
(99.8 %id)
BU942574 mixed (pool of 40 RNAs) .n 768 to 1539 1 to 775       775/815
(95 %)
18 diff
(97.8 %id)
AK124072 synovial membrane tissue from rheumatioidarthritis .n 769 to 2596 1846 to 23   tiling clone, available from FLJ, AAA Submitted on the opposite strand 1824/1824
(100 %)
3 diff
(99.9 %id)
DB334921 synovial membrane tissue from rheumatioidarthritis .n 769 to 1305 1 to 537     Submitted on the opposite strand 537/537
(100 %)
1 diff
(99.9 %id)
CN301039 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 775 to 1505 1 to 728   tiling clone,   728/728
(100 %)
5 diff
(99.4 %id)
AU124150   .n 775 to 1348 2 to 574   capped   573/573
(100 %)
4 diff
(99.4 %id)
AL583390 B cells from Burkitt lymphoma .n 793 to 1864 1071 to 1   tiling clone,   1071/1071
(100 %)
24 diff
(97.8 %id)
CF595746 Stomach, adenocarcinoma .n 802 to 1622 1 to 833       833/882
(94 %)
22 diff
(97.6 %id)
F05743 brain, total brain .n 841 to 1159 1 to 319       319/319
(100 %)
0 diff
(100 %id)
BP266820 thyroid .n 842 to 1419 1 to 579       579/579
(100 %)
4 diff
(99.4 %id)
BM794662 Ascites, stomach .n 850 to 1539 1 to 686       686/686
(100 %)
4 diff
(99.5 %id)
BP257012 Kidney .n 853 to 1436 1 to 585       585/585
(100 %)
3 diff
(99.5 %id)
BM767339 Ascites, stomach .n 862 to 1463 24 to 625       602/625
(96 %)
7 diff
(98.9 %id)
DB021476 testis .n 874 to 1444 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
AI086882 senescent fibroblast .n 875 to 1296 1 to 422     Submitted on the opposite strand 422/422
(100 %)
0 diff
(100 %id)
AI378593 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 880 to 1404 1 to 525     Submitted on the opposite strand 525/525
(100 %)
2 diff
(99.7 %id)
DB009898 colon, tumor tissue .n 888 to 1448 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BM752779 Ascites, stomach .n 891 to 1406 1 to 515       515/515
(100 %)
2 diff
(99.7 %id)
BQ956197 sciatic nerve .n 898 to 1701 1 to 801       801/934
(85 %)
36 diff
(96.2 %id)
BG285043 adenocarcinoma, cell line, Prostate .n 915 to 1718 1 to 784       784/835
(93 %)
18 diff
(97.9 %id)
CB149874 Liver .n 938 to 1531 1 to 591       591/591
(100 %)
3 diff
(99.5 %id)
CB144429 Liver .n 947 to 1308 1 to 362       362/362
(100 %)
0 diff
(100 %id)
CK429644 eye, lacrimal gland .n 971 to 1573 1 to 603       603/603
(100 %)
0 diff
(100 %id)
CB132965 Liver .n 987 to 1600 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
AA337260 endometrium .n 990 to 1253 1 to 264       264/264
(100 %)
0 diff
(100 %id)
AA338013 endometrium .n 1014 to 1288 1 to 275       275/275
(100 %)
0 diff
(100 %id)
BQ019640 Chondrosarcoma, Left Pubic Bone .n 1030 to 1692 677 to 20   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 658/658
(100 %)
3 diff
(99.6 %id)
BQ009936 Chondrosarcoma, Left Pubic Bone .n 1031 to 1694 678 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 660/660
(100 %)
2 diff
(99.7 %id)
CF552094 Pooled muscle (cardiac and skeletal) .n 1031 to 1897 28 to 893       866/894
(96 %)
9 diff
(99.0 %id)
BX474094   .n 1035 to 1544 1 to 506       506/508
(99 %)
6 diff
(98.9 %id)
DA730253   .n 1039 to 1832 2 to 792   capped   791/791
(100 %)
14 diff
(98.3 %id)
CB139196 Liver .n 1064 to 1631 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
CB131841 Liver .n 1067 to 1541 475 to 1     Submitted on the opposite strand 475/475
(100 %)
0 diff
(100 %id)
BP872831 embryonal kidney .n 1101 to 1691 1 to 587       587/587
(100 %)
5 diff
(99.2 %id)
CA426469 cell lines, Chondrosarcoma .n 1141 to 1925 799 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 781/781
(100 %)
5 diff
(99.4 %id)
DB329520 Prostate .n 1420 to 1928 506 to 2       505/506
(99 %)
0 diff
(100 %id)
Z38669 brain, total brain .n 1707 to 1925 219 to 1       219/219
(100 %)
0 diff
(100 %id)
DA049985   .o 1 to 566 2 to 567 exact tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
BU428648 lymph .p 1 to 328 8 to 335   tiling clone,   328/336
(97 %)
8 diff
(97.7 %id)
TI_154149426   .p 1 to 615 69 to 679 E79Q I110D L111F S112E Q113P ... tiling clone,   611/653
(93 %)
33 diff
(95.0 %id)
DB150373 thymus .q 1 to 554 2 to 555 exact tiling clone, capped   554/555
(99 %)
1 diff
(99.9 %id)
DA062834 cerebellum .r 1 to 557 2 to 558 exact tiling clone, capped   557/557
(100 %)
0 diff
(100 %id)
DA377179 thalamus .s 1 to 563 2 to 564 Q115R tiling clone, capped   563/563
(100 %)
2 diff
(99.7 %id)
DA330161 hippocampus .t 1 to 566 2 to 568 L26X V27G V28R R29A V30S ... tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
DA503464 brain .u 1 to 569 2 to 572   tiling clone, capped   571/571
(100 %)
3 diff
(99.5 %id)
DA495760 brain .u 81 to 635 2 to 556   tiling clone, capped   555/555
(100 %)
2 diff
(99.7 %id)
DA304467 hippocampus .u 409 to 980 2 to 573   tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
BF059128 pooled germ cell tumors .u 906 to 1463 558 to 1 exact tiling clone,   558/558
(100 %)
0 diff
(100 %id)
AI638658 pooled germ cell tumors .u 914 to 1429 516 to 1 P44T H48N     516/516
(100 %)
2 diff
(99.7 %id)
BE551737 pooled germ cell tumors .u 942 to 1463 521 to 1       521/521
(100 %)
6 diff
(98.9 %id)
BF056958 pooled germ cell tumors .u 957 to 1463 507 to 1       507/507
(100 %)
0 diff
(100 %id)
BE778688 eye, retinoblastoma .va 1 to 640 1 to 638 R60A L61W A62R L63C P66Q ... tiling clone,   638/957
(66 %)
14 diff
(98.6 %id)
CN286811 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vb-u 1 to 527 1 to 527 exact tiling clone,   527/527
(100 %)
0 diff
(100 %id)
DC375057 brain .vc 1 to 570 3 to 572 exact tiling clone,   572/572
(100 %)
3 diff
(99.5 %id)
BM069742 Islets of Langerhans, Pancreas .vd 1 to 376 1 to 376 exact tiling clone, fully sequenced, AAA   376/376
(100 %)
0 diff
(100 %id)
T29608 lung .vd 157 to 503 1 to 351       351/351
(100 %)
4 diff
(98.9 %id)
BM069510 Islets of Langerhans, Pancreas .vd 177 to 285 109 to 1   fully sequenced,   109/109
(100 %)
3 diff
(97.3 %id)
AA225745   .vd 260 to 384 148 to 24       125/149
(83 %)
0 diff
(100 %id)
AA259205   .vd 261 to 383 1 to 123       123/123
(100 %)
3 diff
(97.6 %id)
AA250896 germinal center B cell .vd 340 to 725 1 to 386   tiling clone,   386/386
(100 %)
0 diff
(100 %id)
R83298 liver and spleen .vd 534 to 843 1 to 310   tiling clone, Submitted on the opposite strand 310/310
(100 %)
1 diff
(99.7 %id)
TI_154111169   .vd 567 to 1356 872 to 83   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 790/799
(98 %)
43 diff
(94.7 %id)
CR736760 liver and spleen .vd 608 to 1371 763 to 1   tiling clone, Submitted on the opposite strand 763/763
(100 %)
4 diff
(99.5 %id)
DA190331 amygdala .vd 769 to 1363 2 to 596   capped   595/595
(100 %)
3 diff
(99.5 %id)
DW409665 Liver .vd 857 to 1177 17 to 337       321/337
(95 %)
6 diff
(98.3 %id)
DW467539 Liver .vd 857 to 1183 17 to 345       329/345
(95 %)
6 diff
(98.3 %id)
BM719973 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vd 861 to 1357 1 to 497   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 497/497
(100 %)
1 diff
(99.8 %id)
TI_151720205   .vd 861 to 1379 573 to 54       520/1300
(40 %)
0 diff
(100 %id)
BG026159 Bone, osteosarcoma, cell line .vd 874 to 1365 12 to 503       492/993
(49 %)
5 diff
(99.5 %id)
AI141015 B-cell, chronic lymphotic leukemia .vd 907 to 1356 451 to 2       450/451
(99 %)
0 diff
(100 %id)
R83389 liver and spleen .vd 908 to 1354 460 to 1     Submitted on the opposite strand 460/462
(99 %)
22 diff
(95.3 %id)
BM676822 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vd 1114 to 1375 264 to 1   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 264/264
(100 %)
2 diff
(99.3 %id)
AA250837 germinal center B cell .vd 1332 to 1544 216 to 1   tiling clone,   216/216
(100 %)
2 diff
(99.1 %id)
N78236 liver and spleen .ve 1 to 265 1 to 266   tiling clone,   266/266
(100 %)
6 diff
(97.8 %id)
N91297 liver and spleen .ve 2 to 371 1 to 379   fully sequenced,   379/379
(100 %)
6 diff
(98.5 %id)
T89518 liver and spleen .ve 3 to 457 1 to 461 V5X S7G L18X A45G G51X ... tiling clone,   461/464
(99 %)
15 diff
(96.8 %id)
R05742 liver and spleen .ve 3 to 341 1 to 340       340/397
(85 %)
6 diff
(98.5 %id)
N59775 liver and spleen .ve 267 to 747 482 to 1   tiling clone,   482/484
(99 %)
10 diff
(98.0 %id)
AI040516 liver and spleen .ve 272 to 746 475 to 1   tiling clone,   475/475
(100 %)
5 diff
(99.0 %id)
N68453 liver and spleen .ve 310 to 746 439 to 1   tiling clone, fully sequenced,   439/439
(100 %)
3 diff
(99.4 %id)
R01120 liver and spleen .ve 389 to 737 356 to 1       356/392
(90 %)
11 diff
(97.2 %id)
AK093917 trachea .vf 1 to 2477 2 to 2474   tiling clone, available from FLJ,   2474/2474
(100 %)
8 diff
(99.7 %id)
DB203600 trachea .vf 1 to 587 2 to 589   capped   588/588
(100 %)
5 diff
(99.2 %id)
DA126945 cerebellum .vf 323 to 855 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
BM931889 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vf 323 to 725 1 to 403       403/403
(100 %)
2 diff
(99.6 %id)
TI_151762929   .vf 323 to 732 475 to 66       410/1050
(39 %)
0 diff
(100 %id)
TI_151758767   .vf 1690 to 2488 877 to 86   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 792/938
(84 %)
14 diff
(98.6 %id)
TI_59394555   .vf 1716 to 2456 84 to 822       739/739
(100 %)
13 diff
(98.3 %id)
BM016162 breast, mammary adenocarcinoma, cell line .vf 1717 to 2456 1 to 738       738/738
(100 %)
13 diff
(98.3 %id)
DA831818 placenta .vf 1719 to 2518 2 to 803   capped   802/803
(99 %)
9 diff
(98.9 %id)
BU620399 cell lines, Chondrosarcoma .vf 1732 to 2477 760 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 742/742
(100 %)
3 diff
(99.6 %id)
BQ000614 Fibrosarcoma .vf 1757 to 2477 734 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 716/716
(100 %)
3 diff
(99.6 %id)
CR616528 Neuroblastoma Cot 25-normalized .vf 1763 to 3117 1 to 1355   tiling clone,   1355/1355
(100 %)
0 diff
(100 %id)
CN301026 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vf 1769 to 1962 1 to 194       194/194
(100 %)
0 diff
(100 %id)
CA420196 Bone, Human Chondrosarcoma Cell Line .vf 1789 to 2477 702 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 684/684
(100 %)
3 diff
(99.6 %id)
CA424388 cell lines, Chondrosarcoma .vf 1790 to 2480 705 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 687/687
(100 %)
3 diff
(99.6 %id)
CB241279 Human Lung Epithelial cells, lung .vf 1791 to 2492 716 to 17   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 700/700
(100 %)
3 diff
(99.6 %id)
BQ018697 lung, Metastatic Chondrosarcoma .vf 1795 to 2477 697 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 679/679
(100 %)
2 diff
(99.8 %id)
CA434991 lung, Metastatic Chondrosarcoma .vf 1802 to 2477 690 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 672/672
(100 %)
2 diff
(99.8 %id)
BQ017870 lung, Metastatic Chondrosarcoma .vf 1809 to 2477 684 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 666/666
(100 %)
3 diff
(99.6 %id)
AL589207 brain .vf 1877 to 2501 1 to 621       621/621
(100 %)
2 diff
(99.7 %id)
EH336429   .vf 1883 to 1944 1 to 62       62/62
(100 %)
0 diff
(100 %id)
CA425731 cell lines, Chondrosarcoma .vf 1888 to 2495 619 to 16   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 604/604
(100 %)
2 diff
(99.7 %id)
BQ020126 Chondrosarcoma, Left Pubic Bone .vf 1917 to 2477 573 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 555/555
(100 %)
4 diff
(99.3 %id)
BG435488 placenta .vf 1920 to 2485 1 to 566   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 566/566
(100 %)
5 diff
(99.2 %id)
BG287878 bladder, transitional cell papilloma, cell line .vf 1943 to 2490 1 to 545   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 545/545
(100 %)
3 diff
(99.5 %id)
BM770008 stomach .vf 1945 to 2471 1 to 526       526/526
(100 %)
1 diff
(99.9 %id)
DB348478 trachea .vf 1946 to 2477 528 to 1       528/528
(100 %)
2 diff
(99.7 %id)
CB118355 Liver .vf 1953 to 2492 547 to 15   AAA Submitted on the opposite strand 533/533
(100 %)
4 diff
(99.3 %id)
AI754837 bone marrow stroma .vf 1954 to 2480 541 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 523/523
(100 %)
2 diff
(99.7 %id)
AI697083 colon .vf 1963 to 2479 513 to 1       513/513
(100 %)
2 diff
(99.7 %id)
AW262901 brain, three pooled meningiomas .vf 1963 to 2477 511 to 1       511/511
(100 %)
2 diff
(99.7 %id)
AI554423 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .vf 1975 to 2480 512 to 11   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 502/502
(100 %)
2 diff
(99.7 %id)
DB576840 hypothalamus .vf 1991 to 2495 1 to 500     Submitted on the opposite strand 500/500
(100 %)
4 diff
(99.2 %id)
AA485911   .vf 2050 to 2430 1 to 381     Submitted on the opposite strand 381/381
(100 %)
0 diff
(100 %id)
AI075652 senescent fibroblast .vf 2102 to 2477 393 to 18   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 376/376
(100 %)
0 diff
(100 %id)
BM789678 stomach .vf 2112 to 2753 1 to 642       642/642
(100 %)
0 diff
(100 %id)
N22130 cochlea, ear .vf 2113 to 2492 414 to 35   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 380/380
(100 %)
0 diff
(100 %id)
AI287851 Kidney, renal cell tumor .vf 2127 to 2468 342 to 1       342/342
(100 %)
0 diff
(100 %id)
AA706844 liver and spleen .vf 2152 to 2477 326 to 1       326/326
(100 %)
0 diff
(100 %id)
AA563758 colon, tumor .vf 2185 to 2480 296 to 1       296/296
(100 %)
0 diff
(100 %id)
BG112909 Bone, osteosarcoma, cell line .vf 2192 to 2937 1 to 736       736/778
(94 %)
15 diff
(98.1 %id)
AA491965 liposarcoma .vf 2199 to 2477 294 to 16   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 279/279
(100 %)
0 diff
(100 %id)
BQ230893 epithelioid carcinoma, Pancreas .vf 2215 to 3073 1 to 867       867/869
(99 %)
17 diff
(98.1 %id)
CB157209 Liver .vf 2224 to 2753 1 to 530       530/530
(100 %)
0 diff
(100 %id)
TI_154049021   .vf 2259 to 3151 955 to 80   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 876/986
(88 %)
27 diff
(97.3 %id)
AA878452 carcinoid, lung .vf 2278 to 2611 1 to 334     Submitted on the opposite strand 334/334
(100 %)
0 diff
(100 %id)
BE219227 carcinoid, lung .vf 2278 to 2767 1 to 490     Submitted on the opposite strand 490/490
(100 %)
0 diff
(100 %id)
EH328197   .vf 2298 to 2368 1 to 71       71/71
(100 %)
0 diff
(100 %id)
TI_154121316   .vf 2338 to 3157 911 to 98   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 814/1016
(80 %)
16 diff
(98.5 %id)
BM797803 Ascites, stomach .vf 2356 to 2721 1 to 366       366/366
(100 %)
0 diff
(100 %id)
AA405265 ovarian tumor, ovary .vf 2384 to 2881 1 to 498   fully sequenced,   498/498
(100 %)
0 diff
(100 %id)
CA429346 Cell Line, Chondrosarcoma .vf 2389 to 3157 789 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 771/771
(100 %)
5 diff
(99.4 %id)
EL948341 eyeball .vf 2399 to 2932 1 to 534       534/534
(100 %)
4 diff
(99.3 %id)
TI_149292266   .vf 2405 to 3157 847 to 104   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 744/875
(85 %)
13 diff
(98.6 %id)
TI_154050202   .vf 2430 to 3148 812 to 95   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 718/985
(72 %)
4 diff
(99.6 %id)
CB242880 Human Lung Epithelial cells, lung .vf 2449 to 3148 718 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 700/700
(100 %)
4 diff
(99.5 %id)
CA413840 Chondrosarcoma Grade II, Left Pelvis .vf 2472 to 3148 694 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 676/676
(100 %)
1 diff
(99.9 %id)
BM561721 duodenal adenocarcinoma, cell line, small intestine .vf 2475 to 3157 1 to 683   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 683/683
(100 %)
0 diff
(100 %id)
BQ019744 Chondrosarcoma, Left Pubic Bone .vf 2475 to 3151 692 to 16   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 677/677
(100 %)
0 diff
(100 %id)
TI_157613205   .vf 2488 to 3157 768 to 93   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 676/740
(91 %)
19 diff
(97.5 %id)
FN047040 breast carcinoma .vf 2527 to 2589 1 to 63       63/63
(100 %)
3 diff
(95.3 %id)
BF878617 lung_tumor .vf 2545 to 2981 1 to 437       437/437
(100 %)
0 diff
(100 %id)
FN072993 breast carcinoma .vf 2560 to 2660 1 to 100       100/101
(99 %)
7 diff
(93.1 %id)
CB156797 Liver .vf 2561 to 3126 566 to 1     Submitted on the opposite strand 566/566
(100 %)
0 diff
(100 %id)
BM696048 eye, human retina .vf 2600 to 3010 1 to 411       411/411
(100 %)
0 diff
(100 %id)
AW019922 cochlea, ear .vf 2604 to 3151 10 to 557   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 548/557
(98 %)
7 diff
(98.8 %id)
R92071 liver and spleen .vf 2609 to 2837 1 to 236   fully sequenced,   236/236
(100 %)
0 diff
(100 %id)
AI207956 brain, oligodendroglioma .vf 2612 to 3076 465 to 1       465/465
(100 %)
0 diff
(100 %id)
FN141288 breast carcinoma .vf 2618 to 2722 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
AI963278 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .vf 2626 to 3151 542 to 17   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 526/526
(100 %)
0 diff
(100 %id)
CN301021 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vf 2635 to 3146 1 to 512       512/512
(100 %)
0 diff
(100 %id)
FN113185 breast carcinoma .vf 2644 to 2715 1 to 71       71/71
(100 %)
4 diff
(94.4 %id)
BP398294 pancreatic islet .vf 2648 to 3147 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
AW074237 2 pooled high-grade transitional celltumors, genitourinary tract .vf 2648 to 3148 501 to 1       501/501
(100 %)
0 diff
(100 %id)
DB362850   .vf 2649 to 3217 570 to 1   tiling clone,   570/570
(100 %)
9 diff
(98.5 %id)
AA629520 lung, lung carcinoma .vf 2652 to 3066 1 to 415     Submitted on the opposite strand 415/415
(100 %)
0 diff
(100 %id)
AI831269 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .vf 2657 to 3216 561 to 1   tiling clone,   561/561
(100 %)
1 diff
(99.9 %id)
BM686094 eye, Retina Foveal and Macular .vf 2658 to 3151 8 to 501   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 494/501
(98 %)
7 diff
(98.7 %id)
AW469393 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .vf 2660 to 3151 492 to 1       492/492
(100 %)
0 diff
(100 %id)
CB159213 Liver .vf 2663 to 3148 524 to 39   AAA Submitted on the opposite strand 486/486
(100 %)
0 diff
(100 %id)
AI797321 colon .vf 2664 to 3148 485 to 1       485/485
(100 %)
0 diff
(100 %id)
BE502100 malignant melanoma, metastatic to lymphnode, skin .vf 2666 to 3157 492 to 1       492/492
(100 %)
0 diff
(100 %id)
AI767387 2 pooled tumors (clear cell type), Kidney .vf 2672 to 3143 472 to 1       472/472
(100 %)
0 diff
(100 %id)
DB521465 testis .vf 2689 to 3148 1 to 460     Submitted on the opposite strand 460/460
(100 %)
0 diff
(100 %id)
BQ005207 Chondrosarcoma, Left Pelvis .vf 2697 to 3148 470 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 452/452
(100 %)
0 diff
(100 %id)
AI151310 placenta .vf 2703 to 3151 463 to 15   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 449/449
(100 %)
0 diff
(100 %id)
AI445050 colon, moderately-differentiated adenocarcinoma .vf 2703 to 3151 459 to 11   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 449/449
(100 %)
0 diff
(100 %id)
CB216992 normal endometrium, mid-secretory phase,cycle day 23, uterus .vf 2715 to 3151 1 to 437   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 437/437
(100 %)
0 diff
(100 %id)
AA961421 pooled germ cell tumors .vf 2716 to 3157 442 to 1       442/442
(100 %)
0 diff
(100 %id)
AI092501 heart .vf 2717 to 3149 433 to 1       433/433
(100 %)
0 diff
(100 %id)
DB377670 placenta .vf 2720 to 3151 432 to 1       432/432
(100 %)
4 diff
(99.1 %id)
AI659457 Prostate .vf 2722 to 3151 430 to 1       430/430
(100 %)
0 diff
(100 %id)
BQ026727 placenta .vf 2727 to 3148 439 to 18   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 422/422
(100 %)
0 diff
(100 %id)
AA553977 colon .vf 2729 to 2939 211 to 1       211/211
(100 %)
0 diff
(100 %id)
AA599289 bone marrow stroma .vf 2732 to 3148 427 to 11   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 417/417
(100 %)
0 diff
(100 %id)
AI224857 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vf 2732 to 3148 427 to 11   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 417/417
(100 %)
0 diff
(100 %id)
AA588839 colon, colon tumor .vf 2733 to 3152 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AA704973 liver and spleen .vf 2735 to 3151 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AI670711 Kidney .vf 2757 to 3152 396 to 1       396/396
(100 %)
0 diff
(100 %id)
BU726131 eye, Retina Foveal and Macular .vf 2758 to 3149 411 to 20   fully sequenced, Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 392/411
(95 %)
0 diff
(100 %id)
CR739821 Prostate .vf 2762 to 3151 1 to 390   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 390/390
(100 %)
0 diff
(100 %id)
AW027922 Kidney .vf 2768 to 3148 381 to 1       381/381
(100 %)
0 diff
(100 %id)
BU501858 epithelioid carcinoma cell line, Pancreas .vf 2780 to 3148 1 to 369   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 369/369
(100 %)
0 diff
(100 %id)
AI523484 aorta .vf 2786 to 3144 359 to 1       359/359
(100 %)
0 diff
(100 %id)
FN158680 breast carcinoma .vf 2787 to 2878 1 to 93       93/93
(100 %)
2 diff
(97.9 %id)
AA708852 uterus .vf 2798 to 3151 354 to 1       354/354
(100 %)
0 diff
(100 %id)
AW301244 Kidney .vf 2798 to 3150 353 to 1       353/353
(100 %)
0 diff
(100 %id)
R92024 liver and spleen .vf 2807 to 3065 265 to 1   fully sequenced,   265/265
(100 %)
0 diff
(100 %id)
BF478213 pooled germ cell tumors .vf 2807 to 3151 345 to 1       345/345
(100 %)
0 diff
(100 %id)
AA774610 heart .vf 2810 to 3151 342 to 1       342/342
(100 %)
0 diff
(100 %id)
T32710 heart .vf 2812 to 3157 346 to 1       346/346
(100 %)
0 diff
(100 %id)
T31683 colon, embryo .vf 2819 to 3151 333 to 1     Submitted on the opposite strand 333/333
(100 %)
0 diff
(100 %id)
AW194076 adenocarcinoma, Pancreas .vf 2823 to 3157 345 to 11   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 335/335
(100 %)
0 diff
(100 %id)
AI587251 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .vf 2843 to 3149 307 to 1       307/307
(100 %)
0 diff
(100 %id)
AA291618 ovarian tumor, ovary .vf 2851 to 3158 307 to 1   fully sequenced,   307/307
(100 %)
2 diff
(99.4 %id)
AI869018 Prostate .vf 2875 to 3151 277 to 1       277/277
(100 %)
0 diff
(100 %id)
AA682659 liver and spleen .vf 2884 to 3213 330 to 1       330/330
(100 %)
0 diff
(100 %id)
AA988515 carcinoid, lung .vf 2908 to 3154 247 to 1       247/247
(100 %)
0 diff
(100 %id)
AI459435 colon .vf 2916 to 3158 243 to 1       243/243
(100 %)
0 diff
(100 %id)
BI490954 cochlea, ear .vf 2921 to 3148 228 to 1   fully sequenced, Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 228/228
(100 %)
0 diff
(100 %id)
AI571090 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .vf 2939 to 3152 214 to 1       214/214
(100 %)
0 diff
(100 %id)
FN049470 breast carcinoma .vf 3057 to 3157 1 to 101       101/101
(100 %)
0 diff
(100 %id)
AK124219 thymus .vg-u 1 to 2165 2 to 2167 exact tiling clone, available from FLJ,   2167/2167
(100 %)
7 diff
(99.7 %id)
DB129938 thymus .vg-u 1 to 582 2 to 583 exact capped   582/582
(100 %)
4 diff
(99.4 %id)
AA113847 Pancreas .vg-u 115 to 517 1 to 405 V82G N83E K84Q F86I V87C     405/405
(100 %)
5 diff
(98.8 %id)
DA085838 cerebellum .vg-u 130 to 586 2 to 458 exact tiling clone, capped   457/457
(100 %)
1 diff
(99.8 %id)
AW894515 nervous_normal .vg-u 196 to 537 17 to 356       340/356
(95 %)
6 diff
(98.4 %id)
BE969964 Pancreas .vg-u 249 to 736 1 to 489       489/489
(100 %)
6 diff
(98.8 %id)
H27850 breast .vg-u 338 to 710 1 to 378   tiling clone,   378/402
(94 %)
8 diff
(98.1 %id)
BG400000 Kidney .vg-u 443 to 1090 1 to 660       660/927
(71 %)
32 diff
(96.6 %id)
BF367994 placenta_normal .vg-u 589 to 765 1 to 176       176/176
(100 %)
1 diff
(99.5 %id)
BF356755 head_neck .vg-u 606 to 762 7 to 161       155/165
(93 %)
3 diff
(98.2 %id)
AA421201   .vg-u 749 to 1168 1 to 420   fully sequenced,   420/420
(100 %)
1 diff
(99.8 %id)
AA421205   .vg-u 749 to 1172 1 to 424   fully sequenced,   424/424
(100 %)
0 diff
(100 %id)
N80387 liver and spleen .vg-u 763 to 1004 1 to 242   fully sequenced,   242/242
(100 %)
3 diff
(98.8 %id)
AA160453 Pancreas .vg-u 856 to 1198 1 to 357       357/357
(100 %)
17 diff
(95.3 %id)
G36655   .vg-u 934 to 1158 225 to 1     Submitted on the opposite strand 225/230
(97 %)
0 diff
(100 %id)
N62663 liver and spleen .vg-u 974 to 1158 185 to 1   fully sequenced,   185/185
(100 %)
0 diff
(100 %id)
AA416664   .vg-u 974 to 1184 211 to 1   fully sequenced,   211/211
(100 %)
0 diff
(100 %id)
AA416582   .vg-u 1038 to 1086 49 to 1   fully sequenced,   49/49
(100 %)
0 diff
(100 %id)
AI342952 carcinoid, lung .vg-u 1058 to 1512 1 to 455     Submitted on the opposite strand 455/455
(100 %)
2 diff
(99.6 %id)
R81245 placenta .vg-u 1134 to 1491 1 to 366       366/370
(98 %)
9 diff
(97.6 %id)
AA353846   .vg-u 1221 to 1565 1 to 346   tiling clone,   346/346
(100 %)
1 diff
(99.8 %id)
AA354007   .vg-u 1221 to 1462 1 to 243       243/243
(100 %)
1 diff
(99.6 %id)
AA092363   .vg-u 1438 to 1565 1 to 129       129/129
(100 %)
1 diff
(99.3 %id)
DB344509 thymus .vg-u 1626 to 2165 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
AA160363 Pancreas .vg-u 1705 to 2171 476 to 1   tiling clone,   476/478
(99 %)
16 diff
(96.7 %id)
R81246 placenta .vg-u 1829 to 2129 302 to 1       302/302
(100 %)
3 diff
(99.1 %id)
BU539577 adenocarcinoma, cell line, breast .vh-u 1 to 788 1 to 797 T4A E12G S17G tiling clone,   797/899
(88 %)
18 diff
(98.0 %id)
BQ347111 nervous_tumor .vh-u 210 to 621 1 to 412       412/412
(100 %)
6 diff
(98.6 %id)
AA077996   .vh-u 518 to 750 1 to 233       233/233
(100 %)
2 diff
(99.2 %id)
AA077392 brain .vh-u 655 to 954 300 to 1   tiling clone,   300/300
(100 %)
1 diff
(99.7 %id)
TI_57243573   .vi 1 to 901 30 to 937 F43L N44I I45* tiling clone,   908/939
(96 %)
36 diff
(96.2 %id)
BI915819 brain .vi 3 to 901 1 to 906 F43L N44I I45* tiling clone,   906/908
(99 %)
30 diff
(96.7 %id)
DB112054 thymus .vj 1 to 580 4 to 583 exact tiling clone, capped   582/582
(100 %)
0 diff
(100 %id)
AW205904   .vk-u 1 to 486 486 to 1 P13X tiling clone,   486/486
(100 %)
0 diff
(100 %id)
BF987447 placenta_normal .vl-u 1 to 424 19 to 442 exact tiling clone,   424/462
(91 %)
2 diff
(99.6 %id)
BF330523 breast_normal .vm-u 1 to 264 282 to 16 exact tiling clone,   267/282
(94 %)
0 diff
(100 %id)
AA078335 placenta .vm-u 52 to 280 229 to 1 exact tiling clone,   229/229
(100 %)
0 diff
(100 %id)
G30907   .vm-u 52 to 280 229 to 1 exact   Submitted on the opposite strand 229/229
(100 %)
0 diff
(100 %id)
192 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb-u, .vc, .vd, .ve, .vf, .vg-u, .vh-u, .vi, .vj, .vk-u, .vl-u, .vm-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI